Importantly, studies have shown that both CB1 and CB2Rs are overexpressed in cancer tissues, and a strong correlation may exist between CBR upregulation and poor prognosis in human tumors in general [75] and in prostate cancer in particular [56]. This evidence concerns the gene CNR1 and cancer.